 |
Most studied contents |
 |
Editorial Board ( 42959 view) |
|
About Journal ( 29413 view) |
|
Indexing &Abstracting ( 21092 view) |
|
Submission Instruction ( 19873 view) |
|
Contact Information ( 18178 view) |
|
Call for Papers ( 16733 view) |
|
Aims and Scope ( 16718 view) |
|
Reviewers List ( 15189 view) |
|
Open Access Policy ( 15137 view) |
|
Call for paper for special issue on Nanoscience and Nanotechnology ( 13588 view) |
|
Is COVID-19 Risk Linked to Blood Type? ( 13560 view) |
|
CrossMark Policy ( 13305 view) |
|
Ethical Principles for Psychological Research ( 12102 view) |
|
Peer Review policy ( 11438 view) |
|
Publishing Ethics ( 10784 view) |
|
Policies of Peer Review ( 9706 view) |
|
Editorial policies ( 8759 view) |
|
Registration Information ( 8135 view) |
|
Ethical Principles for Medical Research ( 8070 view) |
|
Conflicts of Interest ( 7869 view) |
|
Compatibility of Commonly Used IV Drugs ( 7346 view) |
|
COVID-19 resources: serological tests, face masks and benefits of physical activity ( 6539 view) |
|
FDA Approves Vegzelma, a Biosimilar to Bevacizumab, for Six Types of CancerFDA Approves Vegzelma, a Biosimilar to Bevacizumab, for Six Types of Cancer ( 6196 view) |
|
Social isolation can lead to depression in children long after current lockdown ( 6119 view) |
|
International Conference on Cell Science and Molecular Biology December 02-04, 2021 Rome, Italy ( 6068 view) |
|
Webinars for the Week of July 6th ( 5718 view) |
|
What do we know for sure about hydroxychloroquine for COVID-19? Not much ( 5570 view) |
|
Introduction to testing for COVID-19 ( 5505 view) |
|
Upcoming Events of the ACSE ( 5486 view) |
|
COVID-19 Anticoagulation Trials 'Paused' for Futility, Safety ( 5454 view) |
|
Happy Peer Review Week from ACS Publications ( 5404 view) |
|
Korean Biopharmaceutical Firm Celltrion Launches Both Antigen and Antibody Testing Kits in the US ( 5393 view) |
|
From Brain to Behavior: The Search for Biomarkers ( 5313 view) |
|
Poor cardiovascular health may contribute to the development of musculoskeletal disorders ( 5252 view) |
|
Share your COVID experiences with 2 million+ researchers ( 5196 view) |
|
COVID-19: Bacteriophage Could Decrease Mortality ( 4922 view) |
|
FDA approves generic albuterol inhaler to mitigate shortages during pandemic ( 4827 view) |
|
Animal Models of COVID-19 ( 4809 view) |
|
Study Finds No Significant Effect on Infusion Reactions, Cardiac Dysfunction When Switching from Trastuzumab to Biosimilar in HER2-Positive Breast Cancer ( 4663 view) |
|
Cancer deaths set to decline new analysis suggests ( 4661 view) |
|
Experts release appropriate use recommendations for Alzheimer’s disease blood biomarkers ( 4642 view) |
|
Immunotherapies, PARP Inhibitors Show Promise in Early Stage, Triple-Negative Breast Cancers ( 4608 view) |
|
Presymptomatic Atherosclerosis May Contribute to the Development of Alzheimer Disease Later in Life ( 4528 view) |
|
NCPA 2024: In Spite of Challenges, Independent Pharmacies Are Continuing to Serve Patients ( 4446 view) |
|
Statin alternative joins drugs that could reduce heart attack risk ( 4343 view) |
|
MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer ( 4306 view) |
|
Hologic Showcased Latest Advances at Virtual ECR Congress 2020 ( 4306 view) |
|
FDA announces updates to warning for all prescription stimulants ( 4240 view) |
|
Pharmacy chain appeals to older people and vulnerable to get latest Covid-19 booster ( 4179 view) |
|
Navigating FDA Compounding Regulations: Tirzepatide's Removal From the Shortage List and Its Impact on 503A and 503B Facilities ( 4178 view) |
